Literature DB >> 15082684

Memantine for patients with Alzheimer disease.

Thomas E Finucane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15082684     DOI： 10.1001/jama.291.14.1695-a

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

Review 1.  [Effective, indicated--and yet without benefit? The goals of dementia drug treatment and the well-being of the patient].

Authors:  Matthis Synofzik
Journal:  Z Gerontol Geriatr       Date:  2006-08       Impact factor: 1.281

2.  N-methyl-D-aspartate receptor antagonists have variable affect in 3-nitropropionic acid toxicity.

Authors:  Payman Nasr; Timothy Carbery; James W Geddes
Journal:  Neurochem Res       Date:  2008-08-08       Impact factor: 3.996

3.  Memantine for dementia.

Authors:  Rupert McShane; Maggie J Westby; Emmert Roberts; Neda Minakaran; Lon Schneider; Lucy E Farrimond; Nicola Maayan; Jennifer Ware; Jean Debarros
Journal:  Cochrane Database Syst Rev       Date:  2019-03-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.